Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
NAV Announcement and Portfolio Company Update
-
Portfolio and NAV Update
-
CEO Letter to Shareholders
-
Half-year statement of the Liquidity Contract entered into with Oddo BHF SCA
-
Prudential Financial releases 2023 Sustainability Report
-
Dr. Gabriele Weichert takes the helm as President of the Canadian Dermatology Association
-
Novelis Announces Executive Leadership Appointments
-
Big Ridge Announces Grant of Incentive Stock Options and Share-based Compensation
-
Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population
-
EoS Fitness Accelerates Expansion in Q2, Nears 100th Gym Milestone
-
Almirall Launches Act4Impact – its Updated Sustainability Strategy Setting Ambitious Targets for 2030
-
Sapiens Accelerates Growth for Medical Professional Liability Insurers
-
CPSC Awards More than $3.0 Million in Grants to 22 State and Local Governments to Prevent Carbon Monoxide Poisoning
-
Heads of Terms Agreed for US$35 million Revolving Credit Facility
-
Jacobs Awarded Program Manager Owner Advisor Contract at King County South Treatment Plant in Washington State
-
Stream Companies to join Kia Canada's Premier SEO Content Marketing Solutions Program
-
Dotz Nano Completes Sorbent Production Scale-Up and Appoints Head of Engineering
-
Ivanhoe Mines Completes Construction of Kipushi Concentrator Ahead of Schedule
-
North Peak Announces First Hole Drilled at Prospect Mountain North; CFO Transition
-
Aurania Grants Stock Options Including Options in Lieu of Fees to Directors
-
Dexterra Announces Sale of Space Rental Assets
-
Temas Resources Appoints David Caldwell as Chief Operating Officer
-
Kenorland Reports Commencement of Engineering and Baseline Studies at the Frotet Project, Quebec
-
BluSky Carbon Commercializes CO2 Transactions with Carbonfuture GmbH
-
Aehr Test Systems to Announce Fiscal 2024 Fourth Quarter and Full Year Financial Results on July 16, 2024
-
Moderna Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza Vaccine
-
Probe Gold Strengthens Technical Team with the Appointment of VP Exploration
-
Marktuk Unveils AI-Powered Personal Financial Planning App for Seamless Savings and Investing
-
Results from Cognition Therapeutics’ Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease Accepted for Presentation at AAIC
-
CME Group Reports Record June and Q2 2024 Volumes, Reaching New Highs Across Multiple Asset Classes
-
UniDoc Advances Healthcare with H3 Health Cube
-
Trevi Therapeutics to Participate in Upcoming Investor and Healthcare Events
-
PSEG To Announce Second Quarter 2024 Financial Results On July 30
-
Marimaca Announces Channel Sample Results from Mercedes Satellite Target
-
Spectral Medical Provides June Tigris Trial Update
-
CARVYKTI® (ciltacabtagene autoleucel) achieved statistically significant and clinically meaningful improvement in overall survival in landmark CARTITUDE-4 study
-
U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation
-
ATI Announces Webcast for Second Quarter 2024 Results
-
Plus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer
-
ING Americas makes key leadership appointments in Sustainable Finance and Technology, Media, Telecom & Healthcare teams
-
AUXLY ANNOUNCES RESULTS OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS
-
AYR Wellness to Hold Second Quarter 2024 Conference Call on August 7 at 8:00 a.m. ET
-
Yosemite Madera Raises the Stakes for the Yosemite Adventure Contest with a Spectacular "Un-Bear-ably" Cute Prize!
-
Kforce Inc. Announces Date of Second Quarter Earnings Results and Conference Call
-
MEDIPAL and JCR Announce Completion of Clinical Trial Notification Process in Japan for Phase I/II Study of JR-446 for Mucopolysaccharidosis Type IIIB
-
Neurogene to Participate in BMO Genetic Medicines Summit
-
Gibraltar to Present at CJS Securities 24th Annual New Ideas Summer Conference
-
HCLTech and IBM announce GenAI Center of Excellence to support clients with customized AI solutions
-
MariMed Closes Acquisition of Second Maryland Dispensary
-
Altimmune to Participate at Leerink Partners Therapeutics Forum
